Prevalence of HIV Preexposure Prophylaxis Prescribing Among Persons With Commercial Insurance and Likely Injection Drug Use

IMPORTANCE: Although HIV preexposure prophylaxis (PrEP) implementation among persons who inject drugs has been inadequate, national HIV monitoring programs do not include data on PrEP, and specific trends in PrEP use are not well understood. OBJECTIVE: To estimate HIV PrEP uptake among commercially...

Descripción completa

Detalles Bibliográficos
Autores principales: Streed, Carl G., Morgan, Jake R., Gai, Mam Jarra, Larochelle, Marc R., Paasche-Orlow, Michael K., Taylor, Jessica L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277489/
https://www.ncbi.nlm.nih.gov/pubmed/35819784
http://dx.doi.org/10.1001/jamanetworkopen.2022.21346

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277489/
https://www.ncbi.nlm.nih.gov/pubmed/35819784
http://dx.doi.org/10.1001/jamanetworkopen.2022.21346

Ejemplares similares